Bavarian Nordic sells discount shares to help fund Covid-19 vaccine
![Photo: Bavarian Nordic / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12820302.ece/ALTERNATES/schema-16_9/doc7euk7sn6xag7xmizmp9.jpg)
Bavarian Nordic has sold shares worth DKK 1.1bn (USD 175.8m) at DKK 223 per share, which will partly go towards financing the company's further development of the Covid-19 vaccine which the firm has in-licensed from Adaptvac.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.